Ebit Alterar Data
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
Ardelyx USD -30.68M 35.78M 2026-03
aTyr Pharma USD -121.47K 24.59M 2026-03
Biogen USD -243.8M 758.1M 2026-06
Bristol-Myers Squibb USD 299M 3.26B 2026-06
Cipla INR 8.88B 2.74B 2026-06
Clal Biotechnology ILS -5.44M 3.76M 2022-12
Compugen USD -9.02M 65.06M 2026-03
CSL USD 2.64B 116M 2025-12
Curis USD -11.52M 3.64M 2026-03
GlaxoSmithKline GBP 2.6B 312M 2026-06
Grifols EUR 320.55M 91.01M 2025-12
Lakefront Biotherapeutics EUR -63.7M 844.26M 2026-03
Novartis USD 4.73B 549M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
United Therapeutics USD 325.8M 340.4M 2026-03